MicroRNA 96 is a post-transcriptional suppressor of anaplastic lymphoma kinase expression

American Journal of Pathology

Volumn 180, Issue 5, 2012, Pages 1772-1780

  Vishwamitra, Deeksha ^a,b   Li, Yong ^a   Wilson, Desiree ^a   Manshouri, Roxsan ^a   Curry, Choladda V ^c   Shi, Bin ^a   Tang, Xi Ming ^a   Sheehan, Andrea M ^c   Wistuba, Ignacio I ^a   Shi, Ping ^a,d   Amin, Hesham M ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; MICRORNA; MICRORNA 96; PROTEIN KINASE B; SOMATOMEDIN C RECEPTOR; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR JUNB; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ALGORITHM; ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; UPREGULATION;

ALGORITHMS; BASE SEQUENCE; BINDING SITES; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOTAXIS; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; LYMPHOMA, LARGE-CELL, ANAPLASTIC; MICRORNAS; NEOPLASTIC STEM CELLS; RECEPTOR PROTEIN-TYROSINE KINASES; RNA, NEOPLASM; SEQUENCE ALIGNMENT; TRANSFECTION;

EID: 84860231932     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.01.008     Document Type: Article

References (34)

1. S.W. Morris, C. Naeve, P. Mathew, P.L. James, M.N. Kirstein, X. Cui, D.P. Witte ALK, the chromosome 2 gene locus altered by the t(2; 5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK) Oncogene 14 1997 2175 2188
2. S.W. Morris, M.N. Kirstein, M.B. Valentine, K.G. Dittmer, D.N. Shapiro, D.L. Saltman, A.T. Look Fusion of a kinase gene, ALK, to a nucleolar protein gene NPM, in non-Hodgkin's lymphoma Science 263 1994 1281 1284
3. + anaplastic large-cell lymphoma Blood 110 2007 2259 2267
4. M. Soda, Y.L. Choi, M. Enomoto, S. Takada, Y. Yamashita, S. Ishikawa, S. Fujiwara, H. Watanabe, K. Kurashina, H. Hatanaka, M. Bando, S. Ohno, Y. Ishikawa, H. Aburatani, T. Niki, Y. Sohara, Y. Sugiyama, H. Mano Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer Nature 448 2007 561 566
5. Y.P. Mosse, M. Laudenslager, L. Longo, K.A. Cole, A. Wood, E.F. Attiyeh, M.J. Laquaglia, R. Sennett, J.E. Lynch, P. Perri, G. Laureys, F. Speleman, C. Kim, C. Hou, H. Hakonarson, A. Torkamani, M.J. Schork, G.M. Brodeur, G.P. Tonini, E. Rappaport, M. Devoto, J.M. Maris Identification of ALK as a major familial neuroblastoma predisposition gene Nature 455 2008 930 935
6. I. Janoueix-Lerosey, D. Lequin, L. Brugieres, A. Riberio, L. de Pontual, V. Combret, V. Raynal, A. Puisieux, G. Schleiermacher, G. Pierron, D. Valteau-Couanet, T. Frebourg, J. Michon, S. Lyoneet, J. Amiel, O. Delattre Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma Nature 455 2008 967 970
7. R.E. George, T. Sanda, M. Hanna, S. Frohling, W. Luther 2nd, J. Zhang, Y. Ahn, W. Zhou, W.B. London, P. McGrady, L. Xue, S. Zozulya, V.E. Gregor, T.R. Webb, N.S. Gray, D.G. Gilliland, L. Diller, H. Greulich, S.W. Morris, M. Meyerson, A.T. Look Activating mutations in ALK provide a therapeutic target in neuroblastoma Nature 455 2008 975 978
8. Y. Chen, J. Takita, Y.L. Choi, M. Kato, M. Ohira, M. Sanada, L. Wang, M. Soda, A. Kikuchi, T. Igarashi, A. Nakagawara, Y. Hayashi, H. Mano, S. Ogawa Oncogenic mutations of ALK kinase in neuroblastoma Nature 455 2008 971 974
9. R. Chiarle, C. Voena, C. Ambrogio, R. Piva, G. Inghirami The anaplastic lymphoma kinase in the pathogenesis of cancer Nat Rev Cancer 8 2008 11 23
10. R.Y. Bai, T. Ouyang, C. Miething, S.W. Morris, C. Peschel, J. Duyster Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway Blood 96 2000 4319 4327
11. A. Zamo, R. Chiarle, R. Piva, J. Howes, M. Fan Y Chilosi, D.E. Levy, G. Inghirami Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death Oncogene 21 2002 1038 1047
12. M. Marzec, M. Kasprzycka, X. Liu, P.N. Raghunath, P. Wlodarski, M.A. Wasik Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf Oncogene 26 2007 813 821
13. Y.-X. Cui, A. Kerby, F.K.E. McDuff, H. Ye, S.D. Turner NPM-ALK inhibits the p53 tumor suppressor pathway in an MDM2 and JNK-dependent manner Blood 113 2009 5217 5227
14. P.B. Staber, P. Vesely, N. Haq, R.G. Ott, K. Funato, I. Bambach, C. Fuchs, S. Schauer, W. Linkesch, A. Hrzenjak, W.G. Driks, V. Sexl, H. Bergler, M.E. Kadin, D.W. Sternberg, L. Kenner, G. Hoefler The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling Blood 110 2007 3374 3383
15. + anaplastic large-cell lymphoma cells Blood 114 2009 360 370
16. F.C. Kelleher, R. McDermott The emerging pathogenic and therapeutic importance of the anaplastic lymphoma kinase gene Eur J Cancer 46 2010 2357 2368
17. E.L. Kwak, Y.-J. Bang, R. Camidge, A.T. Shaw, G. Solomon, R.G. Maki, S.H. Ou, B.J. Dezube, P.A. Jnne, D.B. Costa, M. Varella-Garcia, W.H. Kim, T.J. Lynch, P. Fidias, H. Stubbs, J.A. Engelman, L.V. Sequist, W. Tan, L. Gandhi, M. Mino-Kenudson, G.C. Wei, S.M. Shreeve, M.J. Ratain, J. Settleman, J.G. Christensen, D.A. Haber, K. Wilner, R. Slagia, G.I. Shapiro, J.W. Clark, A.J. Iafrate Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer N Engl J Med 363 2010 1693 1703
18. D.E. Gerber, J.D. Minna ALK inhibition in non-small lung cancer: from discovery to therapy in record time Cancer Cell 18 2010 548 551
19. J.E. Butrynski, D.R. D'Adamo, J.L. Hornick, P. Dal Cin, C.R. Antonescu, S.C. Jhanwar, M. Ladanyi, M. Capelletti, S.J. Rodig, N. Ramaiya, E.L. Kwak, J.W. Clark, K.D. Wilner, J.G. Christensen, P.A. Jnne, R.G. Maki, G.D. Demetri, G.I. Shapiro Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor N Engl J Med 363 2010 1727 1733
20. H.G. Drexler, S.M. Gignac, R. von Wasielewski, M. Werner, W.G. Dirks Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas Leukemia 14 2000 1533 1559
21. G.A. Calin, C.M. Croce MicroRNA signatures in human cancers Nat Rev Cancer 6 2006 857 866
22. E. Elyakim, E. Sitbon, A. Faerman, S. Tabak, E. Monita, L. Belanis, A. Dov, E.G. Marcusson, C.F. Bennett, A. Chajut, D. Cohen, N. Yerushalmi hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy Cancer Res 70 2010 8077 8087
23. X.-N. Gao, J. Lin, Y.-H. Li, L. Gao, X.-R. Wang, W. Wang, H.-Y. Kang, G.-T. Yan, L.-L. Wang, L. Yu MicroRNA-193a suppresses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia Oncogene 30 2011 3416 3428
24. A. Swarbrick, S.L. Woods, A. Shaw, A. Balakrishnan, Y. Phua, A. Nguyen, Y. Chanthery, L. Lim, L.J. Ashton, R.L. Judson, N. Huskey, R. Blelloch, M. Harber, M.D. Norris, P. Lengyel, C.S. Hackett, T. Preiss, A. Chetcuti, C.S. Sullivan, E.G. Marcusson, W. Weiss, N. L'Etoile, A. Goga miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma Nat Med 16 2010 1134 1140
25. + anaplastic large-cell lymphoma cells Blood 108 2006 2407 2415
26. . Menica, S. Modamio-Høybjør, N. Redshaw, M. Morn, F. Mayo-Marino, L. Olavarrieta, L.A. Aguirre, I. del Castillo, K.P. Steel, T. Dalmay, F. Moreno, M.A. Moreno-Pelayo Mutations in the seed region of human miR-96 are responsible for nonsyndromic progressive hearing loss Nat Genet 41 2009 609 613
27. I.K. Guttilla, B.A. White Coordinate regulation of FOXO1 by miR-72a, miR-96, and miR-182 in breast cancer cells J Biol Chem 284 2009 23204 23216
28. S. Yu, Z. Lu, C. Liu, Y. Meng, Y. Ma, W. Zhao, J. Liu, J. Yu, J. Chen miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer Cancer Res 70 2010 6015 6025
29. M.J. Bueno, I. Perez de Castro, M. Gomez de Cedron, J. Santos, G.A. Calin, J.C. Cigudosa, C.M. Croce, J. Fernandez-Piqueras, M. Malumbres Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression Cancer Cell 13 2008 496 506
30. Y.L. Choi, M. Soda, Y. Yamashita, T. Ueno, J. Takashima, T. Nakajima, Y. Yatabe, K. Takeuchi, H. Hamada, H. Haruta, Y. Ishikawa, H. Kimura, T. Mitsudomi, Y. Tanio, H. Mano ALK Lung Cancer Study Group EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors N Engl J Med 363 2010 1734 1739
31. R. Katayama, T.M. Khan, C. Benes, E. Lifshits, H. Ebi, V.M. Rivera, W.C. Shakespeare, A.J. Iafrate, J.A. Engelman, A.T. Shaw Therapeutic strategies to overcome crizotinib resistance in non-small lung cancer harboring the fusion oncogene EML4-ALK Proc Natl Acad Sci U S A 108 2011 7535 7540
32. A.G. Bader, D. Brown, M. Winkler The promise of microRNA replacement therapy Cancer Res 70 2010 7027 7030
33. J.F. Wiggins, L. Ruffino, K. Kelnar, M. Omotola, L. Patrawala, D. Brown, A.G. Bader Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34 Cancer Res 70 2010 5923 5930
34. D. Pramanik, N.R. Campbell, C. Karikari, R. Chivukula, O.A. Kent, J.T. Mendell, A. Maitra Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice Mol Cancer Ther 10 2011 1470 1480